Drug intelligence / Profile preview

Etiaxil

Development stage
Unknown
Lead developer
The Cooper Companies
Modality
Small Molecules
Administration
Topical
01

Overview

Etiaxil is a line of over-the-counter (OTC) consumer health products developed and marketed by Cooperation Pharmaceutique Francaise (Laboratoires Cooper) for the treatment of excessive sweating, or hyperhidrosis. The core of the Etiaxil range consists of "detranspirant" formulations where the primary active ingredient is aluminum chloride. When applied topically, aluminum chloride reacts with water and proteins within the sweat duct to form a temporary gel-like plug. This plug physically obstructs the sweat gland, significantly reducing the flow of perspiration to the skin's surface for several days. In addition to its mechanical blocking action, the formulation provides antibacterial properties that help mitigate body odor. The Etiaxil brand encompasses various formats, including roll-ons, sprays, and aerosols, with specific versions designed for sensitive skin and different body areas such as the underarms, hands, and feet.

Brand names
Etiaxil
Other names
Etiaxil Detranspirant

Beyond the preview

Go deeper on Etiaxil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Etiaxil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call